Ah Equity Partners Bio Ii, L.L.C. Nautilus Biotechnology, Inc. Transaction History
Ah Equity Partners Bio Ii, L.L.C.
- $144 Million
- Q3 2022
A detailed history of Ah Equity Partners Bio Ii, L.L.C. transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Ah Equity Partners Bio Ii, L.L.C. holds 16,298,006 shares of NAUT stock, worth $37.5 Million. This represents 24.08% of its overall portfolio holdings.
Number of Shares
16,298,006
Previous 16,298,006
-0.0%
Holding current value
$37.5 Million
Previous $43.8 Million
21.19%
% of portfolio
24.08%
Previous 30.79%
Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
77Shares Held
63.1MCall Options Held
14KPut Options Held
1.8K-
Perceptive Advisors LLC New York, NY12.6MShares$29 Million0.78% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$16.5 Million0.6% of portfolio
-
Madrona Venture Group, LLC6.02MShares$13.8 Million15.07% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$8.58 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$6.58 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $287M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...